AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference

November 27, 2019

SALT LAKE CITY--(BUSINESS WIRE)--Nov 27, 2019--

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will attend the Evercore ISI HealthCONx Conference on Tuesday, December 3, 2019 in Boston and the Piper Jaffray 31 st Annual Healthcare Conference on Wednesday, December 4, 2019 in New York, NY.

A live audio webcast of the Evercore ISI HealthCONx Conference presentation on December 3, 2019 at 11:20am ET will be accessible in real time on the “News & Media/Events” section of PolarityTE’s Investor website at www.polarityte.com/news-media/events or via the following link:

Link to Webcast

A live audio webcast of the Piper Jaffray 31 st Annual Healthcare Conference presentation on December 4, 2019 at 3:30pm ET will be accessible in real time on the “News & Media/Events” section of PolarityTE’s Investor website at www.polarityte.com/news-media/events or via the following link:

Link to Webcast

Shortly after the conclusion of each webcast, an audio recording will be available to replay for 30 days by accessing the links referenced above.

About PolarityTE®

PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient’s own tissue and uses the patient’s own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE’s innovative method is intended to promote and accelerate growth of the patient’s tissues to undergo a form of effective regenerative healing. Learn more at www.PolarityTE.com – Welcome to the Shift®.

Forward Looking Statements

Certain statements contained in this release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “intend,” “plan,” “will,” “would,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and other filings with the SEC (copies of which may be obtained at www.sec.gov ). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

POLARITYTE, the POLARITYTE logo, WHERE SELF REGENERATES SELF, and WELCOME TO THE SHIFT are trademarks or registered trademarks of PolarityTE, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191127005146/en/

CONTACT: Investors:

Rich Haerle

VP, Investor Relations

PolarityTE, Inc.

ir@PolarityTE.com

(385) 315-0697Media:

Angela Ziegler

VP, Marketing and Public Relations

PolarityTE, Inc.

AngelaZiegler@polarityte.com

(385) 239-0363

KEYWORD: MASSACHUSETTS NEW YORK UTAH UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH SURGERY STEM CELLS GENETICS FITNESS & NUTRITION BIOTECHNOLOGY

SOURCE: PolarityTE, Inc.

Copyright Business Wire 2019.

PUB: 11/27/2019 08:00 AM/DISC: 11/27/2019 08:01 AM

http://www.businesswire.com/news/home/20191127005146/en